Atlas Trials

SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer

Clinical trial NCT03816553 · COMPLETED

Trial details

NCT number
NCT03816553
Sponsor
Sun Yat-sen University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Cervical CarcinomaMetastatic Cervical Cancer
Start date
2019-01-19
Primary completion
2020-04-30
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.